Crohn’s disease is one of the 2 major forms of inflammatory bowel disease.
Inflammation caused by Crohn’s disease may affect any parts of the gastrointestinal tract,
but it most commonly involves the end of the small bowel, the ileum, and the beginning
of the colon.
The inflammation is not continuous, inflamed segments are usually interrupted by normal
healthy tissues.
Most people experience recurrent flares, when the disease is active, followed by symptom-free
periods of remission.
Symptoms may differ depending on the parts of the digestive tract that are affected.
Most common signs include diarrhea, abdominal pain and tenderness, loss of appetite, weight
loss, fatigue and fever.
Blood in stools occurs when the colon is involved; nausea and vomiting are usually the signs
that the stomach or the first part of the small intestine is affected.
About one third of patients present with perianal disease, including abscess, fistulas and ulcers.
The disease also often manifests outside the intestine, especially in the joints, skin,
and eyes.
Inflammation in Crohn’s disease extends to the entire thickness of the intestinal
wall.
Deep lesions in the mucosa often alternate with areas of mucosal swelling, creating a
characteristic cobblestoned appearance.
Extensive inflammation may cause thickening of the bowel wall and hypertrophy of the mesenteric
fat that wraps around the intestine.
Intestinal wall thickening, together with scar formation, may block the flow of digestive
content, leading to bowel obstruction.
Ulcers can extend through the bowel wall and form tunnels, called fistulas, which may connect
to other loops of the intestine, to abdominal organs, muscles and even skin.
A fistula may become infected and form abscesses, which can be life-threatening if not treated.
In the long-term, Crohn’s disease may increase risks for colon cancers.
The disease has a major peak of onset between the age of 20 and 30, and a smaller peak later
in life.
White individuals, people with family history, and smokers are at higher risks.
The exact mechanism of Crohn’s disease is not fully understood, but it likely involves
both genetic and environmental factors.
Multiple genes are identified, most of which act in the immune system, or in maintaining
the gastrointestinal epithelial barrier.
This barrier separates the gut content from the underlying immune system, preventing the
body from reacting to dietary antigens and resident bacteria of the gut.
A crack in the barrier may increase the chance that the immune system overreacts to non-pathogenic
antigens from the gut content.
Involvement of environmental factors is evidenced by higher disease incidence in developed countries,
especially urban areas.
Diagnosis is made based on a combination of tests and imaging procedures.
Treatments start with dietary management to maintain good nutrition but avoid foods that
may exacerbate symptoms.
Some patients may benefit from nutrition therapy, a special diet given via a feeding tube or
injected into a vein.
The therapy provides nutrition while allowing the bowel to rest, reducing inflammation.
A number of medications can be prescribed depending on disease severity and the patient’s
response to different drugs.
These may include: antidiarrheals, anti-inflammatories, antibiotics, corticosteroids, immunomodulators
and biologics.
Abscesses and fistulas are drained and treated with antibiotics.
Nearly half of patients require at least one surgery to manage recurrent intestinal obstructions
or complicated fistulas or abscesses.
Surgical removal of the diseased parts of the bowel may improve symptoms temporarily,
but is not a cure, because the disease is likely to recur, usually near the reconnected
tissue.